Table 1 Patient baseline characteristics and demographics for consented CB-EST patients
Characteristics | Number (%) |
|---|---|
Gender | |
Male | 26 (87) |
Female | 4 (13) |
Age | 59 (range 49–79) |
Disease site | |
Oropharynx | 18 (60) |
Oral | 5 (17) |
Nasopharynx | 3 (10) |
Larynx | 2 (7) |
Hypopharynx | 1 (3) |
Unknown primary | 1 (3) |
Stage | |
0 | 1 (3) |
1 | 2 (6) |
2 | 13 (43) |
3 | 7 (24) |
4 | 7 (24) |
Nodes | |
0 | 3 (10) |
1 | 7 (24) |
2 | 20 (66) |
Treatment | |
Chemoradiotherapy | 19 (63) |
Surgery and radiotherapy +/− chemotherapy | 9 (30) |
Surgery | 1 (3.5) |
Radiotherapy | 1 (3.5) |
Time post-treatment (months) | Median 4 (IQR, Range 3,13; 1–60) |
Partner | Yes (23) |
No (7) | |